ABBOTT LABORATORIES Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31)
ABBOTT LABORATORIES (ABT) reported Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) of $787.62 million for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-07.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease · last filed 2012-11-07
- ABBOTT LABORATORIES other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2012-09-30 was $787.62M.
- ABBOTT LABORATORIES other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2012-06-30 was -$1.60B, a 504.92% decline year-over-year.
- ABBOTT LABORATORIES other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $656.07M, a 57.64% decline year-over-year.
- ABBOTT LABORATORIES other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2011-12-31 was -$1.74B, a 1596.30% decline year-over-year.
- ABBOTT LABORATORIES other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2011 was -$1.23B.
- ABBOTT LABORATORIES other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2010 was -$2.22B, a 210.06% decline from fiscal 2009.
- ABBOTT LABORATORIES other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2009 was $2.02B.
- ABBOTT LABORATORIES other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2008 was -$3.25B.
| Period end | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 6 month as first filed | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 9 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 9 month as first filed | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 12 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | $787.62M 10-Q · filed 2012-11-07 | -$814.80M derived: sum of 2 quarters · filed 2012-11-07 | -$158.73M 10-Q · filed 2012-11-07 | -$1.90B derived: sum of 4 quarters · filed 2012-11-07 | ||||
| 2012-06-30 | -$1.60B 10-Q · filed 2012-08-07 | -$946.35M 10-Q · filed 2012-08-07 | -$2.68B derived: sum of 3 quarters · filed 2012-08-07 | -$4.12B derived: sum of 4 quarters · filed 2012-11-07 | ||||
| 2012-03-31 | $656.07M 10-Q · filed 2012-05-08 | -$1.08B derived: sum of 2 quarters · filed 2012-05-08 | -$2.52B derived: sum of 3 quarters · filed 2012-11-07 | -$2.12B derived: sum of 4 quarters · filed 2012-11-07 | ||||
| 2011-12-31 | -$1.74B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | -$3.17B derived: sum of 2 quarters · filed 2012-11-07 | -$2.78B derived: sum of 3 quarters · filed 2012-11-07 | -$1.23B 10-K · filed 2012-02-21 | ||||
| 2011-09-30 | -$1.44B 10-Q · filed 2012-11-07 | -$1.44B 10-Q · filed 2011-11-04 | -$1.04B derived: sum of 2 quarters · filed 2012-11-07 | $506.57M 10-Q · filed 2012-11-07 | $507.00M 10-Q · filed 2011-11-04 | $622.65M derived: sum of 4 quarters · filed 2012-11-07 | ||
| 2011-06-30 | $395.74M 10-Q · filed 2012-08-07 | $396.00M 10-Q · filed 2011-08-04 | $1.94B 10-Q · filed 2012-08-07 | $1.95B 10-Q · filed 2011-08-04 | $2.06B derived: sum of 3 quarters · filed 2012-08-07 | $3.21B derived: sum of 4 quarters · filed 2012-08-07 | ||
| 2011-03-31 | $1.55B 10-Q · filed 2012-05-08 | $1.55B 10-Q · filed 2011-05-06 | $1.66B derived: sum of 2 quarters · filed 2012-05-08 | $2.81B derived: sum of 3 quarters · filed 2012-05-08 | $1.16B derived: sum of 4 quarters · filed 2012-05-08 | |||
| 2010-12-31 | $116.08M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | $1.26B derived: sum of 2 quarters · filed 2012-02-21 | -$390.92M derived: sum of 3 quarters · filed 2012-02-21 | -$2.22B 10-K · filed 2012-02-21 | -$2.22B 10-K · filed 2011-02-18 | |||
| 2010-09-30 | $1.15B 10-Q · filed 2011-11-04 | -$507.00M derived: sum of 2 quarters · filed 2011-11-04 | -$2.34B 10-Q · filed 2011-11-04 | -$1.98B derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-06-30 | -$1.65B 10-Q · filed 2011-08-04 | -$3.48B 10-Q · filed 2011-08-04 | -$3.13B derived: sum of 3 quarters · filed 2012-02-21 | -$2.62B derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-03-31 | -$1.83B 10-Q · filed 2011-05-06 | -$1.48B derived: sum of 2 quarters · filed 2012-02-21 | -$969.09M derived: sum of 3 quarters · filed 2012-02-21 | $218.91M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2009-12-31 | $354.91M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | $860.91M derived: sum of 2 quarters · filed 2012-02-21 | $2.05B derived: sum of 3 quarters · filed 2012-02-21 | $2.02B 10-K · filed 2012-02-21 | $2.02B 10-K · filed 2011-02-18 | |||
| 2009-09-30 | $506.00M 10-Q · filed 2010-11-05 | $1.69B derived: sum of 2 quarters · filed 2010-11-05 | $1.66B 10-Q · filed 2010-11-05 | |||||
| 2009-06-30 | $1.19B 10-Q · filed 2010-08-05 | $1.16B 10-Q · filed 2010-08-05 | ||||||
| 2008-12-31 | -$3.25B 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |